Introduction
Expression of the erythrocyte sodium-lithium countertransporter has been proposed as a marker of hypertension and renal dysfunction in diabetes. 1, 2 In healthy subjects, an inverse relationship has been noted between sodium-lithium countertransport (SLC) activity and fractional excretion of lithium; an index of renal proximal tubular function. 3 Correlations have been noted in several studies between SLC activity and the plasma concentrations of urea and creatinine, which can be dependent on renal clearance, 2, 4, 5 and glomerular hyperfiltration in hypertensive patients. 6 These observations raise the possibility that expression of SLC activity is related in some way to renal function. However, limitations in study design has hindered interpretation of these data. Where renal function has been investigated directly, the number of subjects studied has been relatively small and conflicting data have been reported. 3, 7, 8 In contrast, associations between SLC activity and factors associated with renal function have only been noted as secondary observations in studies where larger numbers of subjects have been investigated.
The level of urinary excretion of the 21 kDa retinol-binding protein (RBP) has been shown to be related to filtered load and proximal tubular absorption. In diabetes, RBP may also be a prognostic marker of diabetic renal dysfunction. 9 The aim of the present study was to investigate whether expression of SLC activity demonstrates any relationship with renal function by investigating associations with creatinine clearance and urinary Correspondence: Dr TC Hardman, Heart Function Group, National Heart & Lung Institute, Imperial College School of Medicine, Charing Cross Hospital, London W6 8RF, UK excretion of RBP in a cohort of healthy normotensive subjects.
Materials and methods
We investigated the relationship between SLC activity and RBP excretion in 112 healthy normotensive subjects (55M/57F) aged 20-81 years. Subjects underwent full medical examination including measurement of blood pressure (BP), height, and weight. A fasting blood sample was taken for determination of SLC activity and measurement of plasma lipids, lipoproteins and creatinine. Subjects also provided a timed overnight urine sample for measurement of RBP, creatinine and glomerular filtration rate (GFR).
SLC activity was determined as described previously. 10 In brief, blood was drawn into heparintreated vacutainers. Within 3 h of sampling, erythrocytes were separated by centrifugation from the plasma and buffy coat and held at 4°C until analysis. Determination of SLC activity was performed on the day of collection or after overnight storage at 4°C. Erythrocytes were washed 3 times with an isosmotic magnesium solution. After washing, the supernatant was aspirated and discarded. Packed erythrocytes (5 ml) were suspended in 25 ml of loading solution, and incubated at 37°C for 3 h. At the end of the incubation the erythrocytes were washed five times with washing solution. After the final wash, the supernatant was discarded and the haematocrit of the cell suspension determined.
Erythrocytes (1.6 ml) were suspended in either sodium-rich or sodium-free media. Aliquots were taken in duplicate at 20, 40, and 60 min, placed on ice for 1 min, and then separated by centrifugation for 1 min in a microcentrifuge to estimate lithium efflux. The lithium concentrations in the supernatants of these aliquots were determined by atomic absorption spectrophotometry. SLC activity was determined by subtracting the lithium efflux into the sodium-free media from that into the sodium-rich media, and expressed as the millimoles of lithium released from one litre of erythrocytes per hour. The urinary RBP rate was assessed using radioimmunoassay on a fresh timed overnight urine sample completed on the morning of attendance for the study. 11 RBP excretion rate was determined as a function of the simultaneous creatinine concentration. Samples were stored at −20°C from the time of urine collection to analysis.
Urinary albumin concentration was measured on the same sample by radioimmunoassay using rate nephelometry on a Beckman Array (Beckman, UK), using the standard Beckman microalbumin (MA) reagent. The method has a minimum detection of 2 mg/l. The urinary albumin excretion rates were expressed as an excretion rate and as a function of the simultaneous urine creatinine concentration.
Results are expressed as means (±s.d.) where normally distributed or medians [range] where not normally distributed. Associations between parameters were assessed by product-moment correlation and the data underwent stepwise multiple regression analysis with countertransport activity as the dependent variable. The cohort was subdivided into quartiles on the basis of SLC activity and comparisons of biochemical and laboratory parameters across the four groups were made by ANOVA where data were normally distributed and Kruskall-Wallis tests where data were not normally distributed. Data analyses were performed using SPSS statistical package (SPSS Inc, IL, USA). (Table 1) .
Results
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Elevated SLC activity has shown strong links with predisposition to hypertension. It has been reasoned that if the SLC is a mode of operation of the sodiumhydrogen exchange (SHE). SLC activity could be indicative of plasma membrane SHE; the expression of which is repeated in cell types other than erythrocytes. 12 This hypothesis is appealing since it is easy to envisage how a dysfunction of the SHE in vascular smooth muscle (VSM) or kidney cells could contribute to development of hypertension. Increased SHE could result in an increased sodium influx. A transient increase in intracellular sodium concentration in VSM cells could, via increase in the exchange of internal sodium for external calcium, result in increased intracellular calcium increasing vascular tone. Other mechanisms by which increased activity of the SHE could result in elevated BP are via raised pH in VSM cells stimulating cell proliferation and thereby increasing peripheral resistance or via increased renal tubular sodium retention. Such changes might be reflected in renal function.
The present study did not uncover any significant relationships between markers of renal function and SLC activity. An independent relationship was noted, however, between DBP and SLC activity. No parameter showed any significant association with RBP excretion, the weak trend towards a relationship with albumin excretion is likely to reflect the shared routes of excretion. These findings imply that although associations have been reported between SLC activity and plasma urea and creatinine concen-trations, expression of countertransport activity is not directly related to renal function in healthy subjects.
